These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12689927)

  • 1. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
    Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
    Le Beau MM; Bitts S; Davis EM; Kogan SC
    Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
    Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
    Sohal J; Phan VT; Chan PV; Davis EM; Patel B; Kelly LM; Abrams TJ; O'Farrell AM; Gilliland DG; Le Beau MM; Kogan SC
    Blood; 2003 Apr; 101(8):3188-97. PubMed ID: 12515727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.
    Yaghmaie M; Alimoghaddam K; Mozdarani H; Ghavamzadeh A; Hajhashemi M; Aznab M; Ghaffari SH
    Iran Biomed J; 2012; 16(1):10-7. PubMed ID: 22562027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
    Mozziconacci MJ; Rosenauer A; Restouin A; Fanelli M; Shao W; Fernandez F; Toiron Y; Viscardi J; Gambacorti-Passerini C; Miller WH; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 2002 Nov; 35(3):261-70. PubMed ID: 12353268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PML/RARA chimeric gene on chromosome 2 in a patient with acute promyelocytic leukemia (M3) associated with a new variant translocation: t(2;15;17)(q21;q22;q21).
    Fujishima M; Takahashi N; Miura I; Kobayashi Y; Kume M; Nishinari T; Miura AB
    Cancer Genet Cytogenet; 2000 Jul; 120(1):80-2. PubMed ID: 10913680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
    Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
    Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion.
    Tirado CA; Jahn JA; Scheerle J; Eid M; Meister RJ; Christie RJ; Croft CD; Wallingford S; Heritage DW; Mowrey PN; Meloni-Ehrig AM
    Cancer Genet Cytogenet; 2005 Aug; 161(1):70-3. PubMed ID: 16080960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
    Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
    Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression.
    Wartman LD; Larson DE; Xiang Z; Ding L; Chen K; Lin L; Cahan P; Klco JM; Welch JS; Li C; Payton JE; Uy GL; Varghese N; Ries RE; Hoock M; Koboldt DC; McLellan MD; Schmidt H; Fulton RS; Abbott RM; Cook L; McGrath SD; Fan X; Dukes AF; Vickery T; Kalicki J; Lamprecht TL; Graubert TA; Tomasson MH; Mardis ER; Wilson RK; Ley TJ
    J Clin Invest; 2011 Apr; 121(4):1445-55. PubMed ID: 21436584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Am J Hematol; 1994 Mar; 45(3):212-6. PubMed ID: 8296791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
    Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
    Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two critical hits for promyelocytic leukemia.
    He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
    Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.